New method detects early infection signs after breast cancer reconstruction

A new tool detects early signs of infection after breast reconstruction, potentially preserving implants and improving patient outcomes. Researchers identified specific biomarkers in fluid samples days or weeks before symptoms appear, allowing for preemptive treatment. This method uses metabolomics to analyze small molecules indicative of infection. The findings, published in the Journal of Clinical Investigation, could lead to a point-of-care test, aiding antibiotic stewardship and reducing reconstructive failures.